Thrivent Financial For Lutherans Edwards Lifesciences Corp Transaction History

Thrivent Financial For Lutherans

$52.6 Billion
Q3 2024

A detailed history of Thrivent Financial For Lutherans transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 1,257,962 shares of EW stock, worth $93.2 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

1,257,962

Previous 1,345,238 6.49%

Holding current value

$93.2 Million

Previous $124 Million 33.19%

% of portfolio

0.16%

Previous 0.25%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$59.7 - $93.78 $5.21 Million - $8.18 Million	-87,276 Reduced 6.49%	1,257,962 $83 Million
Q2 2024 Aug 13, 2024	SELL	$84.3 - $94.31 $1.69 Million - $1.89 Million	-19,997 Reduced 1.46%	1,345,238 $124 Million
Q1 2024 May 14, 2024	SELL	$72.54 - $95.56 $22 Million - $29 Million	-303,401 Reduced 18.18%	1,365,235 $130 Million
Q4 2023 Feb 14, 2024	SELL	$61.71 - $77.76 $238,817 - $300,931	-3,870 Reduced 0.23%	1,668,636 $127 Million
Q3 2023 Nov 14, 2023	SELL	$69.28 - $93.38 $195,231 - $263,144	-2,818 Reduced 0.17%	1,672,506 $116 Million
Q2 2023 Aug 14, 2023	BUY	$81.41 - $94.33 $2.29 Million - $2.66 Million	28,174 Added 1.71%	1,675,324 $158 Million
Q1 2023 May 17, 2023	BUY	$74.26 - $84.51 $31.1 Million - $35.4 Million	419,452 Added 34.17%	1,647,150 $136 Million
Q4 2022 Feb 08, 2023	SELL	$68.3 - $87.44 $2.01 Million - $2.58 Million	-29,488 Reduced 2.35%	1,227,698 $91.6 Million
Q3 2022 Nov 14, 2022	SELL	$82.37 - $107.29 $63 Million - $82.1 Million	-764,833 Reduced 37.83%	1,257,186 $104 Million
Q2 2022 Aug 16, 2022	BUY	$86.5 - $128.27 $11.6 Million - $17.2 Million	134,191 Added 7.11%	2,022,019 $192 Million
Q1 2022 May 13, 2022	BUY	$101.96 - $128.34 $15.8 Million - $19.9 Million	155,124 Added 8.95%	1,887,828 $222 Million
Q4 2021 Feb 16, 2022	SELL	$106.37 - $130.68 $6.87 Million - $8.45 Million	-64,630 Reduced 3.6%	1,732,704 $224 Million
Q3 2021 Nov 15, 2021	SELL	$102.91 - $122.75 $1.83 Million - $2.18 Million	-17,768 Reduced 0.98%	1,797,334 $203 Million
Q2 2021 Aug 19, 2021	SELL	$83.84 - $104.76 $8.85 Million - $11.1 Million	-105,545 Reduced 5.5%	1,815,102 $188 Million
Q1 2021 May 17, 2021	BUY	$78.68 - $90.67 $559,021 - $644,210	7,105 Added 0.37%	1,920,647 $161 Million
Q4 2020 Feb 16, 2021	SELL	$71.69 - $91.23 $10.7 Million - $13.7 Million	-149,633 Reduced 7.25%	1,913,542 $175 Million
Q3 2020 Nov 10, 2020	SELL	$67.19 - $87.44 $431,762 - $561,889	-6,426 Reduced 0.31%	2,063,175 $165 Million
Q2 2020 Aug 12, 2020	BUY	$57.54 - $76.95 $79.5 Million - $106 Million	1,382,316 Added 201.13%	2,069,601 $143 Million
Q1 2020 May 15, 2020	BUY	$52.41 - $81.0 $495,588 - $765,936	9,456 Added 1.4%	687,285 $130 Million
Q4 2019 Feb 13, 2020	SELL	$71.7 - $82.09 $24.3 Million - $27.9 Million	-339,566 Reduced 33.38%	677,829 $158 Million
Q3 2019 Nov 14, 2019	SELL	$61.55 - $75.43 $2.29 Million - $2.8 Million	-37,150 Reduced 3.52%	1,017,395 $224 Million
Q2 2019 Aug 13, 2019	BUY	$55.74 - $64.41 $589,784 - $681,522	10,581 Added 1.01%	1,054,545 $195 Million
Q1 2019 May 14, 2019	SELL	$47.89 - $64.05 $273,260 - $365,469	-5,706 Reduced 0.54%	1,043,964 $200 Million
Q4 2018 Feb 15, 2019	BUY	$46.41 - $56.94 $8.67 Million - $10.6 Million	186,846 Added 21.66%	1,049,670 $161 Million
Q3 2018 Nov 15, 2018	SELL	$45.7 - $58.03 $770,456 - $978,327	-16,859 Reduced 1.92%	862,824 $150 Million
Q2 2018 Aug 14, 2018	BUY	$42.45 - $51.3 $11.3 Million - $13.7 Million	267,070 Added 43.6%	879,683 $128 Million
Q1 2018 May 08, 2018	BUY	$37.19 - $47.45 $1.96 Million - $2.5 Million	52,615 Added 9.4%	612,613 $85.5 Million
Q4 2017 Feb 14, 2018	BUY	$33.79 - $39.39 $6,014 - $7,011	178 Added 0.03%	559,998 $63.1 Million
Q3 2017 Nov 14, 2017	BUY	$36.29 - $38.83 $20.3 Million - $21.7 Million	559,820	559,820 $61.2 Million

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

456M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $45.8B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Account

Thrivent Financial For Lutherans Edwards Lifesciences Corp Transaction History